Ribavirin priming pegylated-Interferon combination therapy in chronic hepatitis C patients: study of plasma Ribavirin trough concentrations, anaemia, viral kinetic and genetic variability

被引：0
|
作者：
Munoz-de-Rueda, Paloma [1 ,2 ]
Martin-Lagos, Alicia [1 ]
Quiles, Rosa [1 ,2 ]
Gila, Ana [1 ,2 ]
Belen Martin, Ana [1 ]
Pavon-Castillero, Esther-Jose [1 ]
Ruiz Escolano, Elena [1 ]
Manuel Jimenez-Ruiz, Sergio [1 ]
Ruiz-Extremera, Angeles [2 ,3 ]
Salmeron, Javier [1 ,2 ]
机构：
[1] Hosp Univ San Cecilio, Unit Clin Management Digest Tract, Granada, Spain
[2] CIBERehd, Granada, Spain
[3] Hosp Univ San Cecilio, Serv Pediat, Granada, Spain
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1932
引用
收藏
页码：1141A / 1142A
页数：2
相关论文
共 50 条
  • [21] The effectiveness of pegylated-interferon and ribavirin combination therapy for chronic hepatitis C in an urban clinic setting compared to pivotal clinical trials
    Johnson, TC
    Vaseer, S
    Iqbal, S
    Clain, DJ
    Bodenheimer, HC
    Min, AD
    GASTROENTEROLOGY, 2004, 126 (04) : A724 - A724
  • [22] Pegylated Interferon plus Ribavirin Combination Therapy for Chronic Hepatitis C in Patients with Congenital Coagulation Disorders
    Katsarou, O.
    Theodosiades, G.
    Ioannidou, P.
    Nomikou, E.
    Tsevrenis, B.
    Kouraba, A.
    Deutch, M.
    Terpos, E.
    Dourakis, S.
    Karafoulidou, A.
    ACTA HAEMATOLOGICA, 2008, 120 (02) : 63 - 69
  • [23] Durability of viral response to interferon ribavirin combination in patients with chronic hepatitis C
    Poynard, T
    McHutchison, J
    Davis, G
    Esteban, R
    Albrecht, J
    Ling, M
    Group, I
    JOURNAL OF HEPATOLOGY, 2001, 34 : 23 - 23
  • [24] Therapy Induced Anemia in Patients with Chronic Hepatitis C Receiving Combination Therapy of Pegylated Interferon Alpha and Ribavirin
    Mehdi, Syed Ghazanfar
    Faizi, Karim Shah
    Khan, Rao Saad Ali
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2013, 7 (01): : 204 - 206
  • [25] Risk factors of anaemia in chronic hepatitis C patients treated by interferon alfa and ribavirin combination therapy
    Akbar, Femmy
    Albar, Zulyasri
    Muthalib, Abdul
    Lesmana, Laurentius A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A27 - A27
  • [26] EFFICACY OF TAILORED EXTENTION OF PEGYLATED-INTERFERON AND RIBAVIRIN IN CHRONIC HEPATITS C PATIENTS
    Ikeda, Hiroki
    Suzuki, Michihiro
    Yamada, Norie
    Okamoto, Masaru
    Kobayashi, Minoru
    Takahashi, Hideaki
    Matsunaga, Kotaro
    Okuse, Chiaki
    Matsumoto, Nobuyuki
    Yotsuyanagi, Hiroshi
    Yasuda, Kiyomi
    Itoh, Fumio
    HEPATOLOGY, 2009, 50 (04) : 696A - 696A
  • [27] Consensus interferon and ribavirin in patients with chronic hepatitis C who were nonresponders to prior therapy with either interferon alfa and ribavirin or pegylated interferon and ribavirin
    Chen, K
    Seraphin, P
    Murphy, L
    Shah, N
    HEPATOLOGY, 2005, 42 (04) : 670A - 670A
  • [28] Ophthalmic findings in chronic hepatitis C (CHC) patients treated with pegylated-interferon (PIFN) and ribavirin (RBV)
    Mehta, N
    Murthy, UK
    Kaul, V
    Abruzzese, GP
    Vadrevu, V
    Sveen, JB
    Teitelbaum, C
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S133 - S133
  • [29] Prediction of sustained virological response by ribavirin plasma concentration at week 4 during pegylated-interferon/ribavirin combination therapy in HCV patients
    Maynard, M.
    Gagnieu, M. C.
    Pradat, P.
    Souvignet, C.
    Trepo, C.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S234 - S234
  • [30] The expression kinetics of CD137 in chronic hepatitis C patients treated with pegylated-interferon and ribavirin
    Lee, Sang Jin
    Shin, Jung Woo
    Park, Bo Ryung
    Kim, Chang Jae
    Jung, Seok Won
    Kim, Byunggyu
    Jeong, In Du
    Bang, Sung-Jo
    Park, Neung Hwa
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (05) : 601 - 606
12345